# \[e-drug\] new WHO ART guidelines

**URL:** <https://talk.edrugplus.org/t/e-drug-new-who-art-guidelines/14192>\
**Category:** e-drug\
**Created:** [April 24, 2002, 5:56am UTC](https://talk.edrugplus.org/t/e-drug-new-who-art-guidelines/14192 "2002-04-24T05:56:52Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![vareldzisb](https://avatars.discourse-cdn.com/v4/letter/v/9de0a6/32.png) [@vareldzisb](https://talk.edrugplus.org/u/vareldzisb)\
**Post date:** [April 24, 2002, 5:56am UTC](https://talk.edrugplus.org/t/e-drug-new-who-art-guidelines/14192/1 "2002-04-24T05:56:52Z")

</div>

E-DRUG: new WHO ART guidelines  
--------------------------------------  
[Finally, the new ART guidelines for low-resource settings from WHO.  
WB]

Dear Colleagues

Please find attached the web link to the new WHO ARV Guidelines executive  
summary which can be found on the HIV/AIDS Department website. The  
complete guidelines document will be available on the web soon.

[http://www.who.int/HIV\_AIDS/HIV\_AIDS\_Care/Executive%20sum-April22v3.pdf](http://www.who.int/HIV_AIDS/HIV_AIDS_Care/Executive%20sum-April22v3.pdf)

Basil Vareldzis, M.D., M.P.H.  
Medical Officer / ARV Drugs  
Department of HIV-AIDS  
FCH/HIV/CRE  
World Health Organization  
27 Avenue Appia  
CH-1211 Geneva 27  
Switzerland

Tel: (4122) 791-4670 (direct)  
Tel: (4122) 791-2437 (secretary)  
FAX: (4122) 791-4834

--  
To send a message to E-Drug, write to: e-drug@usa.healthnet.org  
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org  
in the body of the message type: subscribe e-drug OR unsubscribe e-drug  
To contact a person, send a message to: e-drug-help@usa.healthnet.org  
Information and archives: [http://www.healthnet.org/programs/edrug.html](http://www.healthnet.org/programs/edrug.html)
